- The magazine
Tecan and Promega offer variable volume DNA isolation
Publication date: 15 November 2012
Author: kdm communications limited
Tecan and Promega have developed a turnkey workstation for fully automated extraction of gDNA from whole blood samples. Designed to meet the needs of biobanks and high throughput genomic laboratories, the Freedom EVO® HSM workstation provides reliable walkaway extraction of gDNA from large volume blood samples using Promega’s proven ReliaPrep™ Large Volume HT gDNA Isolation System.
The Freedom EVO – HSM workstation is designed to streamline biobanking workflows, offering intelligent one-tube gDNA extraction from up to 32 samples in less than four hours. The compact system is controlled by Tecan’s intuitive TouchTools™ touchscreen interface, and features pre-installed protocols that have been rigorously tested and verified by Promega. Using the platform’s liquid level detection function, the system is able to automatically calculate the reagent volumes for each sample, ensuring efficient walkaway extraction of high quality DNA from 1-10 ml of blood and meeting the specific requirements of next generation sequencing methods.
Caroline Huber, Senior Market Manager at Tecan, commented: “We are very pleased to be working in close collaboration with Promega. Tecan’s expertise in laboratory automation is a great fit with Promega’s genomics tools and reagents, creating a truly unique solution for biobanking applications, backed by the technical support and experience of both companies.”
“This really is an ideal set up for laboratories,” added Promega’s Genomics Marketing Director Tim Sheehy. “As a reagent solutions provider, we know that sample requirements can change from one project to another. The efficiency and reliability of Tecan’s Freedom EVO system make it the ideal platform for integrating the ReliaPrep Large Volume HT gDNA Isolation System, offering customers the flexibility to handle a wide range of sample types and volumes.”
To find out more about Tecan’s Freedom EVO – HSM workstation, visit www.tecan.com/reliaprep
If you enjoyed this article sign-up to receive our bi-weekly email newsletter:
- Elan announces transactions: decisively transforming the company (20 May 2013)
- Verona Pharma: ATS Sunday poster presentations (20 May 2013)
- Novartis drug Afinitor® significantly extended time without disease progression in women with HER2 positive advanced breast cancer (17 May 2013)
- Novo Nordisk reports positive results from first phase 3 trial with long-acting factor IX for treatment of haemophilia B (17 May 2013)
- Novartis wins GBCHealth Business Action on Health Award for social ventures initiative (17 May 2013)
ABB Analytical Measurements | Analytik Jena AG | Aptalis Pharmaceutical Technologies | ASM - Aerosl-Service AG | Azbil BioVigilant, Inc. | B&W Tek, Inc. | Bio-Optronics, Inc. | bioMérieux | BioTrends – Archilex SA | BMG LABTECH GmbH | Bruker Daltonik GmbH | CAMO Software AS | Catalent Pharma Solutions | Chemical Plant Equipment | Chemspec Europe Ltd | CI Precision | Dow Chemical Company Ltd | DSM Biologics | FOSS NIRSystems, Inc. | GE Analytical Instruments | GenScript USA Inc. | Gerresheimer Group | HACH LANGE GMBH | HAMAMATSU PHOTONICS EUROPE | I Holland Limited | IDBS | IONIMED Analytik GmbH | Lonza | MPI Research | Natoli Engineering Company, Inc. | PANalytical B.V. | Patheon Inc | ReAgent | Roche | Siemens AG | Sirius Analytical Instruments Ltd | TSI | Waters Corporation |